Work

Corrigendum to “Lecanemab for treatment of individuals with early Alzheimer’s Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes” [The Journal of Prevention of Alzheimer's Disease (2026) 100507]

Year: 2026

Type: erratum

Abstract: Corrigendum to "Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes" [The Journal of Prevention of Alzheimer's Disease (2026) 100507]

Source: The Journal of Prevention of Alzheimer s Disease

DOI: 10.1016/j.tjpad.2026.100527

Authors: Richard Perry, Christopher Kipps, Maria Eugenia Soto Martín, Marco Bozzali, Giancarlo Logroscino, Sarah Trafford, Shobha Dhadda, Michio Kanekiyo, Amanda Goodwin, Mark Hodgkinson, Steven Hersch, Michael Irizarry, Lynn Kramer, Lutz Froelich

Institutions: Imperial College London, University Hospital Southampton NHS Foundation Trust, Université de Toulouse, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, University of Turin, University of Bari Aldo Moro, Eisai (United Kingdom), Eisai (United States), Heidelberg University, Central Institute of Mental Health, Medizinische Fakultät Mannheim

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,060

OpenAlex ID: W7135206164

Cites:

Cited by:

Related to: